Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Completed 6

Sponsor Class

INDUSTRY 6

Study Type

Interventional 6

Sponsor

Conditions

Warts 6Neoplasms 1Neoplasm Metastasis 1Melanoma 1

Interventions

resiquimod 6lactic acid, salicylic acid drug combination 1human papillomavirus vaccine, L1 type 16, 18 1VP-102 1Sugars 1PRA1 protein, Candida albicans 1Nitric Oxide 1Maltose 1Interferon-alpha 1Cidofovir 1Cholecalciferol 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Warts × resiquimod × Clear all
NCT00114920 2007-02-19

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
88 enrolled

Warts

NCT00115141 2007-02-19

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
88 enrolled

Warts

NCT00116662 2007-02-19

An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Graceway Pharmaceuticals, LLC

Phase 2 Completed
84 enrolled

Warts

NCT00116675 2007-02-19

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Graceway Pharmaceuticals, LLC

Phase 2 Completed
84 enrolled

Warts

NCT00117871 2007-02-19

Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
48 enrolled

Warts

NCT00117923 2007-02-19

Study With a Topical Gel to Treat Common Warts in Adults

Graceway Pharmaceuticals, LLC

Phase 2 Completed
88 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡